hostile

Pension funds Korea’s pension fund NPS rules out investing in MBK’s hostile M&A deals

South Korea’s National Pension Service (NPS) said on Monday it will not participate in investments related to hostile mergers and acquisitions...

Private equity Premier Partners, Praxis Capital lead 2024 Korea PE fundraising

Premier Partners and Praxis Capital are on track to raise 1 trillion won ($680 million) in their respective funds after the two South Korean private...

Mergers & Acquisitions M&A deals in South Korea hit 7-year low in 2024

South Korea’s mergers and acquisitions market shrank further in 2024, with leading business groups seeking to unload non-core assets to bolste...

Mergers & Acquisitions MBK’s Korea Zinc takeover attempt to spur search for white knights

North Asia-focused private equity firm MBK Partners Ltd.’s attempt to take control of Korea Zinc Inc. and the country’s plan to require ...

Leadership & Management Corporate management disputes spring up in S.Korea

An unprecedentedly high number of South Korean corporations have become targets of unwanted hostile takeover attempts or have been embroiled in mana...

Leadership & Management MBK, Young Poong seek $1.5 bn hostile bid for Korea Zinc

MBK Partners Ltd., the North Asia-focused private equity firm, is set to take over Korea Zinc Inc. through an up to 2 trillion won ($1.5 billion) ho...

Corporate strategy Lotte leader Shin Dong-bin stresses pivot to AI-centered innovation

Shin Dong-bin, chairman of South Korea’s retail, food and chemicals conglomerate Lotte, on Friday urged affiliate executives to ramp up effort...

Leadership & Management Hankook vows to prevent hostile bids after MBK tender offer fails

Hankook & Company Co., the holding company of South Korea’s largest tire maker Hankook Tire & Technology Co., said on Tuesday it will ...

Corporate strategy Lotte Group's Shin stresses unlearning as key to innovation

Disregarding existing ways and being open to new opportunities are challenging in South Korea’s large conglomerates, where a strict corporate ...

Bio & Pharma Management dispute over S.Korea’s CTC Bio heats up

A management dispute over a South Korean pharmaceutical maker CTC Bio Inc. specializing in animal drugs is intensifying as another medical company h...